Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

irbesartan-50-granules(38 products available)
indiabuy
Supplier Type
Supplier Region
Purity
Package

Irbesartan

  • CAS:138402-11-6
  • MF:C25H28N6O
  • MW:428.53
  • EINECS:604-078-2
Melting point::
180-181°C
Boiling point::
648.6±65.0 °C(Predicted)
Density :
1.30±0.1 g/cm3(Predicted)
storage temp. :
2-8°C
solubility :
DMSO: >25mg/mL
pka:
4.16±0.10(Predicted)
form :
powder
color :
white to off-white
Merck :
14,5083
Symbol(GHS) 

GHS07,GHS08,GHS09,GHS02
Signal word 
Danger
Hazard statements 
H413
Precautionary statements 
P501-P273
More Chemical Properties

Irbesartan    138402-11-6

contract manufacturer
Note:Purity: 99% | Package: 1 kg,5 kg, 10 kg,25kg and 1 MT
1Y Maharashtra
Phone: +91-8655777550
Tel: +91-8655777550
Whatsapp: +91-8655777550
Product catalog: 244
Inquiry

IRBESARTAN    138402-11-6

Manufacturer
Note:Purity: 95-99 % | Package: 1-5 gm, the rest upon order
1Y Telangana
Phone: +91-9731133411
Tel: +91-9731133411
Whatsapp: +91- 9731133411
Product catalog: 546
Inquiry

Irbesartan   138402-11-6

Trader
Maharashtra
Tel: 91-22-27576333
Product catalog: 151
Inquiry

Irbesartan   138402-11-6

Manufacturer
New Delhi
Tel: 91-40-66725000
Product catalog: 53
Inquiry

Irbesartan   138402-11-6

India
Tel: 91-265-2280550
Web:
Product catalog: 119
Inquiry

Irbesartan    138402-11-6

Pack Size
Purity
Availability
Price
200mg
United States Pharmacopeia (USP) Reference Standard
In stock Inquiry
97255
Update time:2024-08-21
New Delhi
Phone: 1-800-309-5000
Web:
Product catalog: 157135
Inquiry

Irbesartan >98% (HPLC)    138402-11-6

Pack Size
Purity
Availability
Price
100mg
In stock 1week
7234.44
Update time:2024-08-21
New Delhi
Phone: 91-98-91111994
Web:
Product catalog: 50852
Inquiry

Irbesartan    138402-11-6

1(MOQ)

Note:Purity: >98.0%(T)(HPLC)
New Delhi
Phone: 1-800-425-7889
Web:
Product catalog: 26979
Inquiry